Skip to main content

Stock Movers: Tesla Robotaxi Debut, Circle's Stablecoin Surge, Hims & Hers Partnership Collapse

Bloomberg PodcastsJune 23, 20256 min1,224 views
34 connections·35 entities in this video→

Market Close Overview

  • πŸ“Š The S&P 500 saw a broad advance with 399 names gaining ground, particularly in the last 10-15 minutes of trading.
  • πŸ“‰ Only the energy sector finished in the red, with 22 out of 23 big-cap energy names declining, except for Kinder Morgan.

Tesla's Robotaxi Rollout

  • πŸš€ Tesla shares surged approximately 8.25%, marking its biggest intraday rise since late April.
  • πŸ’‘ The company launched its long-promised driverless taxi service to a limited number of riders in Austin, Texas, on Sunday.
  • βœ… The debut was described as largely uneventful and a critical milestone for the stock's bulls.

Circle's Stablecoin Legislation Boost

  • πŸ“ˆ Circle (CRCL) shares extended gains for a third consecutive session, rallying significantly.
  • πŸ’° This surge is attributed to the Senate passing stablecoin legislation last week.
  • πŸš€ The company has seen an over 800% increase since its IPO on June 5th.

Hims & Hers Partnership Dissolution

  • πŸ“‰ Hims & Hers (HIMS) shares plummeted over 34% after Novo Nordisk scrapped its partnership.
  • ⚠️ Novo Nordisk cited deceptive marketing by Hims in selling compounded versions of its obesity drug.
  • πŸ—£οΈ Hims CEO Andrew Dudum called Novo's comments misleading, stating Novo pressured Hims to steer patients to Wegovy, which Hims refused.
  • πŸ“‰ Novo Nordisk ADRs also fell over 5% on the news.

Other Notable Stock Movements

  • 🏦 Northern Trust shares rose about 8% on reports that Bank of New York Mellon approached the company for a possible merger, which could create a large custodian bank.
  • πŸ’» Super Micro Computer shares fell nearly 10% after announcing plans to offer $2 billion in convertible senior notes due in 2030 to fund share repurchases and business expansion.
  • πŸ’Š Compass Pathways (CMPS) ADRs dropped 49% after its psilocybin drug trial for depression showed only a 3.6% symptom reduction compared to a placebo, disappointing investors.
Knowledge graph35 entities Β· 34 connections

How they connect

An interactive map of every person, idea, and reference from this conversation. Hover to trace connections, click to explore.

Hover Β· drag to explore
35 entities
Chapters3 moments

Key Moments

Transcript23 segments

Full Transcript

Topics17 themes

What’s Discussed

TeslaRobotaxiDriverless CarsCircleStablecoin LegislationHims & HersNovo NordiskObesity DrugsPartnershipNorthern TrustBank of New York MellonMergerSuper Micro ComputerConvertible NotesCompass PathwaysPsilocybinDepression Treatment
Smart Objects35 Β· 34 links
CompaniesΒ· 13
ConceptsΒ· 13
MediaΒ· 1
PeopleΒ· 3
ProductsΒ· 5